New LEVEL UP Period 2 Data Shows Patients Who Switched From Dupilumab to Upadacitinib Achieved Higher Treatment Targets in AD

Press/Media

Period	25 Oct 2024

Media coverage

Title	New LEVEL UP Period 2 Data Shows Patients Who Switched From Dupilumab to Upadacitinib Achieved Higher Treatment Targets in AD
Media name/outlet	Dermatology Times
Country/Territory	United States
Date	25/10/24
URL	https://www.dermatologytimes.com/view/new-level-up-period-2-data-shows-patients-who-switched-from-dupilumab-to-upadacitinib-achieved-higher-treatment-targets-in-ad
Persons	Niamh Moore